Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
9.15
-0.13 (-1.40%)
At close: Jun 27, 2025, 4:00 PM
9.12
-0.03 (-0.33%)
After-hours: Jun 27, 2025, 7:56 PM EDT
Sage Therapeutics Employees
Sage Therapeutics had 353 employees as of December 31, 2024. The number of employees decreased by 134 or -27.52% compared to the previous year.
Employees
353
Change (1Y)
-134
Growth (1Y)
-27.52%
Revenue / Employee
$134,289
Profits / Employee
-$1,003,958
Market Cap
572.98M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SAGE News
- 5 days ago - Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 9 days ago - SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE - Business Wire
- 11 days ago - These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News - Benzinga
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect - Accesswire
- 11 days ago - Top 3 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 12 days ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - PRNewsWire
- 12 days ago - Sage Therapeutics Stock Soars 35% After Sale to Supernus. What We Know. - Barrons
- 12 days ago - Supernus Pharma to acquire Sage Therapeutics in up to $795 million deal - Reuters